These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 752023

  • 21. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
    Ibsen H, Leth A, McNair A, Giese J.
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():123s-125s. PubMed ID: 396064
    [Abstract] [Full Text] [Related]

  • 22. A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II).
    Keim HJ, Drayer JI, Case DB, Lopez-Ovejero J, Wallace JM, Weber MA, Laragh JH.
    N Engl J Med; 1976 Nov 18; 295(21):1175-7. PubMed ID: 980020
    [No Abstract] [Full Text] [Related]

  • 23. The immediate pressor response to saralasin in man: evidence against sympathetic activation and for intrinsic angiotensin II-like myotropism.
    Mathias CJ, Unwin RJ, Pike FA, Frankel HL, Sever PS, Peart WS.
    Clin Sci (Lond); 1984 May 18; 66(5):517-24. PubMed ID: 6231156
    [Abstract] [Full Text] [Related]

  • 24. Angiotensin blockade: its clinical significance.
    Streeten DH, Anderson GH, Dalakos TH.
    Am J Med; 1976 May 31; 60(6):817-24. PubMed ID: 1020761
    [Abstract] [Full Text] [Related]

  • 25. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R, Vetter W, Furrer J, Nussberger J, Schmied U, Siegenthaler W.
    Dtsch Med Wochenschr; 1976 Mar 12; 101(11):398-401. PubMed ID: 1253700
    [Abstract] [Full Text] [Related]

  • 26. Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man.
    Pettinger WA, Mitchell HC.
    N Engl J Med; 1975 Jun 05; 292(23):1214-7. PubMed ID: 236513
    [Abstract] [Full Text] [Related]

  • 27. Sympathetic nerve hyperactivity in high-renin hypertension effects of saralasin infusion.
    DeQuattro V, Barbour BH, Campese V, Finck EJ, Miano L, Esler M.
    Mayo Clin Proc; 1977 Jun 05; 52(6):369-73. PubMed ID: 865132
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The effect of saralasin in the chronically cannulated ewe in the early puerperium.
    Broughton Pipkin F, Turner SR, Wallace C.
    J Physiol; 1984 Jan 05; 346():19-26. PubMed ID: 6366186
    [Abstract] [Full Text] [Related]

  • 33. Angiotensin II blockade in normal subjects and essential hypertensive patients.
    MacGregor GA, Dawes PM.
    Clin Sci Mol Med Suppl; 1976 Dec 05; 3():193s-196s. PubMed ID: 1071606
    [Abstract] [Full Text] [Related]

  • 34. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
    Fagard R, Amery A, Lijnen P, Reybrouck T.
    Eur J Clin Invest; 1977 Dec 05; 7(6):473-9. PubMed ID: 415868
    [Abstract] [Full Text] [Related]

  • 35. Clinical pharmacology of angiotensin antagonists.
    Pettinger WA, Mitchell HC.
    Fed Proc; 1976 Nov 05; 35(13):2521-5. PubMed ID: 976494
    [Abstract] [Full Text] [Related]

  • 36. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
    Marks LS, Maxwell MH, Kaufman JJ.
    Ann Intern Med; 1977 Aug 05; 87(2):176-82. PubMed ID: 889198
    [Abstract] [Full Text] [Related]

  • 37. Effect of the specific angiotensin antagonist (Sar1) (Ala8) angiotensin II on blood pressure and the renin-angiotensin system in the conscious pregnant ewe and fetus.
    Broughton Pipkin F, O'Brien PM.
    Am J Obstet Gynecol; 1978 Sep 01; 132(1):7-15. PubMed ID: 696788
    [Abstract] [Full Text] [Related]

  • 38. The diagnostic and therapeutic uses of saralasin in renal transplant hypertension.
    Zawada ET, Maxwell MH, Marks LS, Lee DB, Kaufman JJ.
    J Urol; 1980 Feb 01; 123(2):148-52. PubMed ID: 6986475
    [Abstract] [Full Text] [Related]

  • 39. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T, Doi K, Ogihara T, Ichihara K, Hata T, Kumahara Y.
    Prog Biochem Pharmacol; 1976 Feb 01; 12():174-89. PubMed ID: 1019163
    [Abstract] [Full Text] [Related]

  • 40. Effect of saralasin upon plasma catecholamines in hypertensive patients.
    Vlachakis ND, Ribeiro AB, Krakoff LR.
    Am Heart J; 1978 Jan 01; 95(1):78-80. PubMed ID: 619593
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.